drugset / Trial / NCT02215941

Study to Characterize the Pharmacokinetics and Safety of TV-45070 Ointment in Healthy Volunteers

NCT02215941 ↗

Phase 1 Completed 45 enrolled Teva Branded Pharmaceutical Products R&D, Inc.
RandomizedParallel-groupTriple-blindOther

Summary

The primary objective of this study is to characterize the pharmacokinetics of TV-45070 in plasma following single and multiple-dose topical application of 8% TV-45070 ointment.

Timeline

Start
2014-08
Primary completion
2014-11
Completion
2015-02

Drugs

EvaluationDrugModalityDoseRoute
Subject funapide Small molecule 8 % Topical

Indications

No indication recorded.